Relmada Therapeutics, Inc.

JPMORGAN CHASE & CO RLMD

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

39,203

Value ($000)

274

Weight

0.0%

2020 Q2 - 2026 Q2 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	274	0.0%	39,203	6/30/2026
2025 Q2	8/12/2025	3	0.0%	5,103	6/30/2025
2025 Q1	5/12/2025	0	0.0%	158	3/31/2025
2024 Q4	2/12/2025	20	0.0%	37,700	12/31/2024
2024 Q3	11/8/2024	1,021	0.0%	315,059	9/30/2024
2024 Q2	8/12/2024	1,058	0.0%	352,616	6/30/2024
2024 Q1	5/10/2024	818	0.0%	175,978	3/31/2024
2023 Q4	2/12/2024	78	0.0%	18,796	12/31/2023
2023 Q3	11/14/2023	3	0.0%	859	9/30/2023
2023 Q2	8/11/2023	2	0.0%	859	6/30/2023
2023 Q1	5/18/2023	47	0.0%	20,981	3/31/2023
2022 Q4	2/13/2023	54	0.0%	15,503	12/31/2022
2022 Q3	11/14/2022	633	0.0%	17,092	9/30/2022
2022 Q2	8/11/2022	304	0.0%	15,976	6/30/2022
2022 Q1	5/11/2022	427	0.0%	15,850	3/31/2022
2021 Q4	2/11/2022	167	0.0%	7,424	12/31/2021
2021 Q3	11/12/2021	283	0.0%	10,786	9/30/2021
2021 Q2	8/12/2021	334	0.0%	10,442	6/30/2021
2021 Q1	5/12/2021	324	0.0%	9,191	3/31/2021
2020 Q4	2/19/2021	259	0.0%	8,070	12/31/2020
2020 Q3	11/12/2020	262	0.0%	6,982	9/30/2020
2020 Q2	8/11/2020	277	0.0%	6,186	6/30/2020